AST-120 for functional abnormalities of HDL in patients with CKD

Trial Profile

AST-120 for functional abnormalities of HDL in patients with CKD

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Jan 2017

At a glance

  • Drugs Charcoal (Primary)
  • Indications Arteriosclerosis; Kidney disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Jan 2017 Last checked against University Hospital Medical Information Network - Japan
    • 15 Aug 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan
    • 17 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top